During the past decade, Chicago Eye Specialists conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chicago Eye Specialists" are "Glaucoma, Open-Angle" (2 trials), "Cataract" (1 trials), "Glaucoma" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "Chicago Eye Specialists" in a lesser frequency.

Most popular intervention types in "Chicago Eye Specialists" are "Drug" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator: Timolol 0.5%" (1 trials), "Bimatoprost SR" (1 trials), "Cataract Surgery" (1 trials), "Clobetasol propionate" (1 trials) and "Sham: Applicator Without Needle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chicago Eye Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Chicago Eye Specialists". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chicago Eye Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chicago Eye Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".